EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury

Rong Ji, Zengyu Zhang, Zhuohang Liu, Kaicheng Yang, Xueyu Mao, Min Chu, Yong Wang, Jing Zhao iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202503803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Rong Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Exosomes, Dynamins, Brain Ischemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Public Health Discipline Construction Project of Shanghai Minhang District Health Commission, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia/reperfusion injury (CIRI) remains a major clinical challenge due to the lack of effective neuroprotective strategies. Here, hUMSC‐derived exosomes (H‐Exo) were isolated and administered intranasally (15 µg/mouse/day for 3 days) in a mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model. Animals were randomly assigned to three groups: Sham, MCAO/R, and H‐Exo–treated MCAO/R mice. H‐Exo efficiently penetrated the blood–brain barrier, accumulated within the ischemic penumbra, and was internalized by neurons and glial cells. Treatment with H‐Exo markedly improved neurological function both in vivo and in vitro. Mechanistically, H‐Exo inhibits neuronal ferroptosis by preserving mitochondrial dynamics and alleviating oxidative stress. Transcriptomic analysis identified ARRDC3 as a previously unrecognized ferroptosis‐associated gene that was upregulated after ischemia but suppressed by H‐Exo treatment. ARRDC3 exacerbates neuronal ferroptosis by promoting Drp1‐dependent mitochondrial fragmentation. Proteomic profiling further identified CRYAB as an abundant exosomal cargo mediating the neuroprotective effects of H‐Exo. Pharmacological inhibition of CRYAB with NCI‐41356 partially reversed the anti‐ferroptotic effects of H‐Exo, confirming its essential role. Collectively, this study reveals the CRYAB–ARRDC3–Drp1 axis as a key regulator linking mitochondrial dynamics to ferroptosis and highlights H‐Exo as a promising non‐invasive therapeutic approach for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryExosomesDynaminsBrain IschemiaNeuroprotective AgentsNeuroprotectionAnimalsMiceMaleMice, Inbred C57BLInfarction, Middle Cerebral ArteryNeuronsFerroptosisMitochondriaHumansOxidative Stress

Stichwörter der Autor:innen

ARRDC3/DRP1 axiscerebral ischemia‐reperfusion injuryexosomesferroptosismitochondrial dynamics

Substanzen

DynaminsDnm1l protein, mouseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China.
  • Department of Rehabilitation Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Geriatrics, Shanghai Geriatric Medical Center, Shanghai, China.
  • Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Institute of Healthy Yangtze River Delta, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Jing Zhao

Förderung

  • National Natural Science Foundation of China
  • Public Health Discipline Construction Project of Shanghai Minhang District Health Commission
  • China Postdoctoral Science Foundation

Zitieren

APA

Ji, R., Zhang, Z., Liu, Z., Yang, K., Mao, X., Chu, M., Wang, Y., & Zhao, J. (2026). Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503803

Vancouver

Ji R, Zhang Z, Liu Z, Yang K, Mao X, Chu M, et al. Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503803

BibTeX
@article{Ji2026,
  author = {Ji, Rong and Zhang, Zengyu and Liu, Zhuohang and Yang, Kaicheng and Mao, Xueyu and Chu, Min and Wang, Yong and Zhao, Jing},
  title = {Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202503803}
}
Kostenlos starten →